Journal of Cardiovascular Disease Research
AN UPDATE ON CURRENT USAGE OF SGLT2-INHIBITORS IN HEART FAILURE WITH REDUCED EJECTION FRACTION: SPECIAL FOCUS ON DAPAGLIFLOZIN
Dr. Jay Shah, Dr Johann Christopher, Dr. Saketkant, Dr. Soumik Goswami, Dr. Biswajit Aich,Dr. Sameer K. Muchhala,
JCDR. 2021: 2054-2063
» PDF